Video Interview: Tamas Masztis
We talk about Tamas' career and what's going on in the cell therapy space...
What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!
Here, we speak with Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company. Tamas built one of the first cell therapy supply chains for Europe and Israel. The successful implementation of this complex, centralized end-to-end supply chain involving the transportation of patient cells has been critical to launching Kite’s cell therapies in 24 countries in the region to date.
In part 1 of this interview, we ask Tamas what inspired his interest in sourcing and supply chains, and find out more about his role at Kite.
In part 2, we delve into the wider cell and gene therapy space, including supply chain challenges and the impact of the pandemic.
